Source:http://linkedlifedata.com/resource/pubmed/id/19012065
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2009-3-2
|
pubmed:abstractText |
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder characterized by progressive loss of spinal cord and cortical motoneurons. Despite improved understanding of the mechanisms underlying ALS, in clinical practice the management of ALS remains essentially supportive and focused on symptom relief. However, over the past few years stem cell research has expanded greatly as a tool for developing potential new therapies for treating incurable neurodegenerative diseases.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1477-2566
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
11
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
18-25
|
pubmed:meshHeading |
pubmed-meshheading:19012065-Adult,
pubmed-meshheading:19012065-Aged,
pubmed-meshheading:19012065-Amyotrophic Lateral Sclerosis,
pubmed-meshheading:19012065-Female,
pubmed-meshheading:19012065-Follow-Up Studies,
pubmed-meshheading:19012065-Hematopoietic Stem Cell Transplantation,
pubmed-meshheading:19012065-Humans,
pubmed-meshheading:19012065-Magnetic Resonance Imaging,
pubmed-meshheading:19012065-Male,
pubmed-meshheading:19012065-Middle Aged,
pubmed-meshheading:19012065-Transplantation, Autologous,
pubmed-meshheading:19012065-Treatment Outcome
|
pubmed:year |
2009
|
pubmed:articleTitle |
Treatment of amyotrophic lateral sclerosis patients by autologous bone marrow-derived hematopoietic stem cell transplantation: a 1-year follow-up.
|
pubmed:affiliation |
Department of Neurosurgery and Neurology, Akay Hospital, Ankara, Turkey. halukdeda@gmail.com
|
pubmed:publicationType |
Journal Article,
Clinical Trial, Phase II
|